Table 1.

Patient Demographics

	PC (n=433)		PCB (n=417)
Group	Male (n=253)	Female (n=180)	Male (n=210)	Female (n=207)
Age ≥ 65	117 (46.2%)	72 (40.0%)	96 (45.7%)	81 (39.1%)
ECOG PS1*	152 (60.6%)	108 (60.3%)	125 (60.1%)	122 (59.2%)
Prior RT	24 (9.5%)	13 (7.2%)	18 (8.6%)	15 (7.2%)
Prior Wt Loss ≥ 5%	77 (30.4%)	44 (24.4%)	50 (23.8%)	67 (32.4%)
Stage IV non-recurrent	200 (79.4%)	137 (76.1%)	160 (76.2%)	150 (72.5%)
Histology: Adeno or NOS	223 (88.8%)	157 (87.2%)	179 (85.2%)	187 (90.3%)
Large cell	17 (6.8%)	12 (6.7%)	12 (5.7%)	5 (2.4%)
BAC	6 (2.4%)	5 (2.8%)	7 (3.3%)	5 (2.4%)
Other Histology	5 (2.0%)	6 (3.3%)	12 (5.7%)	10 (4.8%)
>2 metastatic sites involved	148 (58.5%)	81 (45.0%)	108 (51.4%)	108 (52.2%)
Liver involved	52 (20.6%)	21 (11.7%)	42 (20.0%)	48 (23.2%)

^*6 cases were excluded from PS rates due to unknown PS.